Literature DB >> 8831931

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

A G Bostom1, D Shemin, K L Lapane, P Sutherland, M R Nadeau, P W Wilson, D Yoburn, L Bausserman, G Tofler, P F Jacques, J Selhub, I H Rosenberg.   

Abstract

Maintenance dialysis patients experience an exceedingly high incidence of arteriosclerotic cardiovascular disease (CVD) events that are poorly predicted by traditional CVD risk factor indices. We evaluated the prevalence of three non-traditional CVD risk factors, i.e. hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) Lp(a)) excess, and combined hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess, in maintenance dialysis patients. Fasting total plasma homocysteine (Hcy), fibrinogen, Lp(a), glucose, and total and HDL cholesterol levels, and traditional CVD risk factor (i.e. glucose tolerance, smoking, hypertension, dyslipidemia) prevalences were assessed in 71 dialysis patients and 71 age, sex, and race matched Framingham Study controls free of clinical renal disease, with normal serum creatinine (< or = 1.5 mg/dl). Mean plasma Hcy 23.7 vs. 9.9 microM, P = 0.0001), fibrinogen (457 vs. 309 mg/dl, P = 0.0001), and Lp(a) (30 vs. 17 mg/dl, P = 0.0070) levels were substantially increased in the dialysis patients. Matched odds ratios (with 95% confidence intervals), dialysis patients/controls, for hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess, alone or combined, were markedly greater in the dialysis patients, with no evidence of confounding by the traditional CVD risk factors: hyperhomocysteinemia, 105.0 (29.9-368.9); hyperfibrinogenemia, 16.6 (6.6-42.0); Lp(a) excess, 3.5 (1.5-8.4); all three combined 35.0 (5.7-199.8). Given in vitro evidence that Hcy, Lp(a), and fibrinogen interact to promote atherothrombosis, combined hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess may contribute to the high incidence of vascular disease sequelae experienced by dialysis patients, which is inadequately explained by traditional CVD risk factors. Controlled, prospective studies of well-characterized maintenance dialysis cohorts are urgently required to substantiate this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831931     DOI: 10.1016/0021-9150(96)05865-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Renal dysfunction and acceleration of coronary disease.

Authors:  M W Yerkey; S J Kernis; B A Franklin; K R Sandberg; P A McCullough
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

2.  Bidirectional association between glaucoma and chronic kidney disease: A systematic review and meta-analysis.

Authors:  Faye Yu Ci Ng; Harris Jun Jie Muhammad Danial Song; Benjamin Kye Jyn Tan; Chong Boon Teo; Emmett Tsz Yeung Wong; Pui Yi Boey; Ching-Yu Cheng
Journal:  EClinicalMedicine       Date:  2022-06-08

3.  Coronary-artery calcium scores using electron beam CT in patients with chronic renal failure.

Authors:  Chan-Duck Kim; Ji-Hyung Cho; Hyuk-Joon Choi; Min-Hwa Jang; Hyeog-Man Kwon; Jun-Chul Kim; Sun-Hee Park; Jong-Min Lee; Dong-Kyu Cho; Yong-Lim Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

4.  Effects of renal replacement therapy on plasma lipoprotein(a) levels.

Authors:  Sylvia Rosas; Marshall Joffe; Megan Wolfe; Kenneth Brayman; Daniel J Rader
Journal:  Am J Nephrol       Date:  2007-12-05       Impact factor: 3.754

5.  Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort.

Authors:  Sofia Sederholm Lawesson; Joakim Alfredsson; Karolina Szummer; Mats Fredrikson; Eva Swahn
Journal:  BMJ Open       Date:  2015-06-23       Impact factor: 2.692

6.  Comparison of Chronic Hemodialysis Patients under Strict Volume Control with respect to Cardiovascular Disease.

Authors:  Fadime Ersoy Dursun; Ali Ihsan Gunal; Ercan Kirciman; Ilgin Karaca; Mustafa Necati Dagli
Journal:  Int J Nephrol       Date:  2019-07-03

7.  Association between chronic kidney disease and open-angle glaucoma in South Korea: a 12-year nationwide retrospective cohort study.

Authors:  Jun-Soo Ro; Jong Youn Moon; Tae Kwann Park; Si Hyung Lee
Journal:  Sci Rep       Date:  2022-03-01       Impact factor: 4.379

8.  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.

Authors:  Jannis Kountouras; Apostolis Papaefthymiou; Stergios A Polyzos; Evangelos Kazakos; Elisabeth Vardaka; Maria Touloumtzi; Maria Tzitiridou-Chatzopoulou; Christos Liatsos; Ioanna-Konstantina Sgantzou; Jürg Knuchel; Michael Doulberis
Journal:  Arq Bras Cardiol       Date:  2022-09       Impact factor: 2.667

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.